United Laboratories International Holdings Ltd

UNJ

Company Profile

  • Business description

    United Laboratories International Holdings Ltd is mainly engaged in the research and development, production and sales of pharmaceuticals. The company operates in three segments: Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Bulk medicine segment, followed by Finished products. The majority of the company's sales are generated in China, followed by Europe, India and other countries.

  • Contact

    No. 6 Fuk Wang Street
    Yuen Long Industrial Estate
    New Territories
    Hong Kong
    HKG

    T: +852 26871033

    http://www.tul.com.cn

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    17,000

Stocks News & Analysis

stocks

Netflix: A business that’s nearly flawless

Streaming giant’s stellar results had areas of softness; currency tailwinds drive guidance raise.
stocks

Trump’s US dollar assault is fuelling CBA’s rise

A recent $1 billion investment in CBA by Texas based fund manager expresses concern for the outlook of the USD.
stocks

Insignia Financial: Revised deal still attractive

The offer price is well above our fair value.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,000.001.40-0.02%
CAC 407,850.43106.021.37%
DAX 4024,240.82198.920.83%
Dow JONES (US)45,010.29507.851.14%
FTSE 1009,061.4937.680.42%
HKSE25,538.07408.041.62%
NASDAQ21,020.02127.330.61%
Nikkei 22541,729.02557.701.35%
NZX 50 Index12,822.3128.250.22%
S&P 5006,358.9149.290.78%
S&P/ASX 2008,734.302.90-0.03%
SSE Composite Index3,582.300.440.01%

Market Movers